| Followers | 1246 |
| Posts | 47864 |
| Boards Moderated | 0 |
| Alias Born | 04/04/2008 |
Wednesday, February 12, 2025 9:38:09 PM
Took some here in the after hours.
Bullish
Recent VBIO News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2026 09:29:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2026 08:36:14 PM
- Valion Bio's Velocity Bioworks Secures Exclusive Commercial License to LarmorBio's BioScan-NMR™ Platform • PR Newswire (US) • 05/14/2026 08:31:00 PM
- VALION BIO REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS • PR Newswire (US) • 05/14/2026 08:05:00 PM
- Valion Bio to Report First Quarter 2026 Financial Results on May 14, 2026 • PR Newswire (US) • 05/11/2026 12:01:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/08/2026 09:02:54 PM
- Valion Bio Celebrates Grand Opening of Velocity Bioworks Biomanufacturing Facility in San Antonio, Anchoring Domestic Production of Entolimod™ • PR Newswire (US) • 05/06/2026 12:08:00 PM
- VALION BIO RECEIVES FIRST FDA-PRECEDENT STUDY PROTOCOL FROM NIAID FOR ENTOLIMOD™; FEDERAL AGENCY TO FULLY FUND BLA-ENABLING IN VIVO PROGRAM AND CO-NAVIGATE FDA SUBMISSION • PR Newswire (US) • 05/05/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/04/2026 08:08:18 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/04/2026 08:07:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/04/2026 08:05:18 PM
- Valion Bio Appoints Melinda Lackey as General Counsel • PR Newswire (US) • 05/04/2026 08:05:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/30/2026 12:15:02 PM
- VALION BIO BRIEFS PENTAGON LEADERSHIP ON ENTOLIMOD™ FOR ACUTE RADIATION SYNDROME • PR Newswire (US) • 04/28/2026 12:01:00 PM
